190 related articles for article (PubMed ID: 32985141)
1. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy.
Zhou H; Qin F; Chen C
Adv Healthc Mater; 2021 Mar; 10(5):e2001277. PubMed ID: 32985141
[TBL] [Abstract][Full Text] [Related]
2. Radiation-responsive scintillating nanotheranostics for reduced hypoxic radioresistance under ROS/NO-mediated tumor microenvironment regulation.
Dou Y; Liu Y; Zhao F; Guo Y; Li X; Wu M; Chang J; Yu C
Theranostics; 2018; 8(21):5870-5889. PubMed ID: 30613268
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-active nanoparticles used in tumor theranostic.
Wang Y; Shang W; Niu M; Tian J; Xu K
Int J Nanomedicine; 2019; 14():3705-3722. PubMed ID: 31190820
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-tropic nanozymes as oxygen generators for tumor-favoring theranostics.
Gao F; Wu J; Gao H; Hu X; Liu L; Midgley AC; Liu Q; Sun Z; Liu Y; Ding D; Wang Y; Kong D; Huang X
Biomaterials; 2020 Feb; 230():119635. PubMed ID: 31767443
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives.
Thambi T; Park JH; Lee DS
Chem Commun (Camb); 2016 Jun; 52(55):8492-500. PubMed ID: 27225824
[TBL] [Abstract][Full Text] [Related]
6. A multifunctional nanotheranostic for the intelligent MRI diagnosis and synergistic treatment of hypoxic tumor.
Song R; Zhang M; Liu Y; Cui Z; Zhang H; Tang Z; Chen X; Wu H; Yao Z; He M; Bu W
Biomaterials; 2018 Aug; 175():123-133. PubMed ID: 29804000
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-Triggered Self-Assembly of Ultrasmall Iron Oxide Nanoparticles to Amplify the Imaging Signal of a Tumor.
Zhou H; Guo M; Li J; Qin F; Wang Y; Liu T; Liu J; Sabet ZF; Wang Y; Liu Y; Huo Q; Chen C
J Am Chem Soc; 2021 Feb; 143(4):1846-1853. PubMed ID: 33397097
[TBL] [Abstract][Full Text] [Related]
8. Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors.
Liu Y; Jiang Y; Zhang M; Tang Z; He M; Bu W
Acc Chem Res; 2018 Oct; 51(10):2502-2511. PubMed ID: 30234960
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical tumor acidity-responsive self-assembled magnetic nanotheranostics for bimodal bioimaging and photodynamic therapy.
Yang HY; Jang MS; Li Y; Fu Y; Wu TP; Lee JH; Lee DS
J Control Release; 2019 May; 301():157-165. PubMed ID: 30905667
[TBL] [Abstract][Full Text] [Related]
10. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
11. Intelligent gold nanostars for
Zhang L; Yang XQ; Wei JS; Li X; Wang H; Zhao YD
Theranostics; 2019; 9(19):5424-5442. PubMed ID: 31534494
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-Responsive Multifunctional "Trojan Horse" Nanogel as a Nanotheranostic for Combined Chemotherapy and Photodynamic Anticancer Therapy.
Wang Y; Zu M; Ma X; Jia D; Lu Y; Zhang T; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2020 Nov; 12(45):50896-50908. PubMed ID: 33107728
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional NIR-responsive poly(vinylpyrrolidone)-Cu-Sb-S nanotheranostic agent for photoacoustic imaging and photothermal/photodynamic therapy.
Hou M; Yan C; Chen Z; Zhao Q; Yuan M; Xu Y; Zhao B
Acta Biomater; 2018 Jul; 74():334-343. PubMed ID: 29753138
[TBL] [Abstract][Full Text] [Related]
15. Research progress on tumor hypoxia-associative nanomedicine.
Xu XX; Chen SY; Yi NB; Li X; Chen SL; Lei Z; Cheng DB; Sun T
J Control Release; 2022 Oct; 350():829-840. PubMed ID: 36100192
[TBL] [Abstract][Full Text] [Related]
16. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
[TBL] [Abstract][Full Text] [Related]
17. All-in-One Theranostic Nanomedicine with Ultrabright Second Near-Infrared Emission for Tumor-Modulated Bioimaging and Chemodynamic/Photodynamic Therapy.
Xu J; Shi R; Chen G; Dong S; Yang P; Zhang Z; Niu N; Gai S; He F; Fu Y; Lin J
ACS Nano; 2020 Aug; 14(8):9613-9625. PubMed ID: 32806021
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-responsive AIEgens for precise disease theranostics.
Liu D; Liang M; Fan A; Bing W; Qi J
Luminescence; 2024 Jan; 39(1):e4659. PubMed ID: 38286609
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment-Responsive Theranostic Nanoplatform for in Situ Self-Boosting Combined Phototherapy through Intracellular Reassembly.
Liu Y; Jing J; Jia F; Su S; Tian Y; Gao N; Yang C; Zhang R; Wang W; Zhang X
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6966-6977. PubMed ID: 31965785
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared light-responsive nanomaterials for cancer theranostics.
Kim H; Chung K; Lee S; Kim DH; Lee H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
